Perspective Therapeutics (CATX): Director bought ~$50K

~$50K

Approx. value · 22K sh @ $2.27

71K

Holds after · shares reported

Traded

Mar 28, 2025

Filed

Apr 1, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Mar 28, 2025 · this disclosureInsiderDirector purchased ~$50K of CATX shares in the open market

What came next

1. Mar 28, 2025Insider · 2 peopleInsiders: 3 purchases (~$135K)
2. Mar 31, 2025Insider · 2 peopleInsiders: 2 purchases (~$132K)

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Perspective Therapeutics

For Perspective Therapeutics, OQRO holds 3 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CATX page.

Other recent filings by Robert F Iii Williamson, Director

• SEC Form 4 at Perspective Therapeutics (CATX)Apr 1, 2025
• SEC Form 4 at Perspective Therapeutics (CATX)Nov 27, 2024
• SEC Form 4 at Perspective Therapeutics (CATX)Nov 27, 2024

The full history of Robert F Iii Williamson, Director is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Perspective Therapeutics

• SEC Form 4Nov 13, 2026
• SEC Form 4Nov 13, 2026
• SEC Form 4Nov 12, 2026
• SEC Schedule 13DNov 12, 2026
• SEC Form 4Apr 1, 2025
• SEC Form 4Apr 1, 2025

Everything OQRO holds on this company is on its CATX page.